Pharmaceutical extraction helps separate desired compounds from complex mixtures during drug manufacturing. The solvent used in this process can influence extraction efficiency, purification requirements and batch consistency. Methylene Dichloride (MDC), also known as dichloromethane or methylene chloride, is used in selected pharmaceutical processes because of its solvent properties and limited solubility in water.
However, choosing pharma-grade MDC involves more than selecting a suitable chemical. Manufacturers must assess purity, water content, impurity levels, pharmacopeial compliance and batch consistency. These factors help maintain process control and ensure that the solvent meets the requirements of its intended application.
The Role of Pharma Grade MDC in Pharmaceutical Extraction
MDC has the chemical formula CH₂Cl₂ and is a clear, colourless, volatile liquid. Its solvent characteristics make it useful in certain extraction systems, particularly where organic compounds need to be separated from an aqueous phase.
During liquid-liquid extraction, a compound distributes between two liquid phases according to its chemical properties and the conditions of the process. MDC may help transfer the target compound into the required phase, supporting subsequent separation and purification.
Its pharmaceutical applications may include:
• Extraction and separation: Facilitating the transfer of selected compounds between liquid phases.
• Purification: Supporting the removal of unwanted materials during appropriate processing stages.
• Chemical synthesis: Serving as a solvent where compatible with the manufacturing route.
• Intermediate processing: Assisting in the preparation and isolation of pharmaceutical intermediates.
The effectiveness of MDC depends on compound solubility, solvent ratios, temperature and phase behaviour. Selecting the correct grade is equally important because variations in solvent quality can introduce additional uncertainty into an otherwise controlled process.
Key Quality Considerations When Selecting MDC
1. Pharmacopeial Compliance
Pharmaceutical manufacturers must ensure that the solvent meets the quality requirements applicable to its intended use. Pharma-grade MDC may be specified against the United States Pharmacopeia/National Formulary (USP/NF), British Pharmacopoeia (BP), European Pharmacopoeia (EP) and Indian Pharmacopoeia (IP).
These standards provide defined requirements for identity, quality and testing. Manufacturers should verify the applicable specification and review batch-specific documentation before approving the material.
A supplier’s product description alone is not sufficient. The Certificate of Analysis (CoA) should be checked against the agreed acceptance criteria to confirm that the supplied batch meets the required specifications.
2. Purity and Impurity Control
Solvent impurities can affect processing behaviour and may introduce substances that require additional control. For this reason, manufacturers should assess the impurity profile and relevant chemical quality parameters of the MDC grade they intend to use.
Important checks include:
• Acidity: Helps establish whether the material meets the specified acidity limit.
• Free chlorine: Supports assessment against the prescribed test requirement.
• Residue on evaporation: Indicates the amount of residue remaining after the solvent evaporates.
• Overall purity: Must be evaluated using the applicable specification and analytical tests.
The supplied PUROSOLV MDC specifications set a maximum residue on evaporation of 20 ppm. Maintaining appropriate controls over these parameters can support consistent incoming material quality and reduce avoidable process variability.
3. Water Content and Physical Properties
Water content can influence solvent behaviour in extraction systems where phase separation and solubility are important. Manufacturers should therefore confirm that moisture levels remain within the required specification.
The supplied PUROSOLV MDC specification sets a maximum water content of 0.02% m/m.
Physical properties also help verify material consistency. The supplied specifications include a relative density of 1.320–1.332 at 20°C and a refractive index of 1.423–1.425 at 20°C ± 0.5°C.
These results should be interpreted alongside other quality tests. A clear, colourless appearance alone cannot establish that a solvent meets pharmaceutical requirements.
How MDC Quality Influences Extraction Performance
Extraction efficiency depends on both solvent characteristics and process conditions. A suitable solvent must interact appropriately with the target compound while supporting the required separation from other materials.
Variations in water content, impurities or other quality parameters may affect process behaviour, depending on the specific extraction system. Consistent solvent specifications help manufacturers work with more predictable incoming materials.
Process development teams should evaluate solvent suitability through appropriate studies, considering:
• Solubility of the target compound.
• Solvent-to-feed ratio.
• Temperature and mixing conditions.
• Separation efficiency and compound recovery.
• Downstream purification requirements.
MDC should be selected based on these process-specific factors rather than its chemical properties alone. Appropriate evaluation helps establish whether it is suitable for the intended manufacturing route.
Residual Solvent Control and Documentation
Residual solvent management is another important consideration. Dichloromethane is classified as an ICH Q3C Class 2 residual solvent, so manufacturers must control its levels in accordance with applicable requirements.
Residual MDC may be influenced by solvent quantities, washing conditions, evaporation efficiency, drying time and equipment configuration. Suitable process controls and analytical testing are therefore necessary to verify that residual levels meet the relevant limits.
Gas chromatography is commonly used for residual solvent analysis. Methods should be appropriate for their intended application and validated where required.
Documentation supports this quality process. Manufacturers should review the CoA, product specifications, Safety Data Sheet (SDS) and batch identification details. These records assist material approval, traceability, audits and investigations when quality deviations occur.
Storage and Handling Requirements
MDC is volatile and requires appropriate storage and handling practices. The supplied PUROSOLV product information recommends storing it in an airtight container protected from light.
Manufacturers should ensure that containers are compatible with the solvent and that material labels remain legible throughout storage and use. The supplied product information lists MS drums, stainless steel containers, HDPE or HM-HDPE containers and glass bottles as packaging options, subject to suitability.
Personnel should use appropriate personal protective equipment (PPE), adequate ventilation and established handling procedures. The supplier’s SDS should guide storage, exposure controls and emergency response.
Why Purosolv Is a Trusted Choice for Pharma Grade MDC
Choosing a solvent supplier requires confidence in product specifications, documentation and supply support. Pharmaceutical manufacturers need these elements to work together, particularly when solvent quality affects extraction and downstream purification.
Purosolv offers pharma-grade MDC specified against USP/NF, BP, EP and IP requirements. Its product information defines relevant quality parameters, including water content, acidity, free chlorine, relative density, refractive index and residue on evaporation. This helps customers assess the material against their incoming quality requirements.
Purosolv also draws on DFPCL’s experience in the solvent industry. Its wider quality and service framework includes document support, digital Certificates of Analysis, a customer portal and distribution capabilities.
These features can support pharmaceutical manufacturers by helping them:
• Evaluate solvent quality against defined specifications.
• Access batch-related documentation for quality review.
• Maintain material traceability.
• Coordinate solvent procurement and supply requirements.
• Review product information for appropriate storage and handling.
The final decision should always reflect the manufacturer’s process, quality system and applicable regulatory requirements. Purosolv’s specifications and documentation provide a practical starting point for evaluating MDC for pharmaceutical extraction.
Conclusion
Pharma-grade MDC plays an important role in selected pharmaceutical extraction processes, where solvent quality can influence separation, purification and process consistency. Selecting the appropriate grade requires careful attention to pharmacopeial compliance, purity, water content, physical properties and residual solvent control.
Purosolv supports these requirements through its specified pharmaceutical-grade MDC, defined quality parameters and documentation support. By combining appropriate supplier qualification with process-specific evaluation, pharmaceutical manufacturers can strengthen incoming material control and make more informed decisions about solvent selection.
Frequently Asked Questions (FAQs)
1. What is pharma-grade MDC used for in pharmaceutical extraction?
MDC is used in selected extraction, separation, purification and intermediate processing applications. Its suitability depends on the compound, solvent system and manufacturing process.
2. Which pharmacopeial standards apply to pharmaceutical-grade MDC?
The supplied PUROSOLV MDC is specified against USP/NF, BP, EP and IP requirements. Manufacturers should confirm the applicable specification for their intended use.
3. Why is water content important when selecting MDC?
Water content can influence solvent behaviour in certain extraction systems. The supplied PUROSOLV MDC specification sets a maximum water content of 0.02% m/m.
4. How is residual MDC controlled in pharmaceutical manufacturing?
Residual MDC is managed through suitable process design, solvent removal, drying conditions and appropriate analytical testing. Gas chromatography is commonly used to measure residual solvent levels.
5. Why choose Purosolv for pharma-grade MDC?
Purosolv provides MDC with defined quality specifications and documentation support. These resources help manufacturers assess incoming solvent quality, maintain traceability and evaluate suitability for their pharmaceutical processes.